Oncolytic vaccinia virus harboring aphrocallistes vastus lectin exerts anti-tumor effects by directly oncolysis and inducing immune response through enhancing ROS in human ovarian cancer
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2024.150355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Guohui Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China. Hauptthemen laut MEDLINE: Vaccinia virus, Ovarian Neoplasms, Oncolytic Virotherapy, Reactive Oxygen Species. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Aphrocallistes vastus lectin (AVL) is a Ca2+ dependent C-type lectin produced by sponges. Previous studies have demonstrated that oncolytic vaccinia virus harboring AVL (oncoVV-AVL) effectively triggers cell death in various tumors. However, the effects of oncoVV-AVL on human ovarian cancer (OV) remain unknown. This study aims to investigate the mechanism-of-action of oncoVV-AVL in human OV cell lines and in tumor-bearing nude mice. We found that oncoVV-AVL could directly induce apoptosis and autophagy in ovarian cancer cells. Additionally, our results showed that oncoVV-AVL increased the serum levels of mouse IFN-γ (mIFN-γ), leading to the activation of M1-polarized macrophages. Conversely, NADPH, a reducing agent by providing reducing equivalents, reduced the production of mIFN-γ, and suppressed M1-polarization of macrophage. Based on these findings, we propose that oncoVV-AVL not only contributes to direct cytolysis, but also enhances host immune response by promoting ROS levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
- College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China; Hangzhou Gongchu Biotechnology Co., Ltd., Hangzhou, China. Electronic address: lgc@zstu.edu.cn.
- College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China. Electronic address: chenkan@zstu.edu.cn.
Zitieren
APA
Zhang, G., Wang, Q., Yuan, R., Zhang, Y., Chen, K., Yu, J., Ye, T., Jia, X., Zhou, Y., Li, G., & Chen, K. (2024). Oncolytic vaccinia virus harboring aphrocallistes vastus lectin exerts anti-tumor effects by directly oncolysis and inducing immune response through enhancing ROS in human ovarian cancer. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150355
Vancouver
Zhang G, Wang Q, Yuan R, Zhang Y, Chen K, Yu J, et al. Oncolytic vaccinia virus harboring aphrocallistes vastus lectin exerts anti-tumor effects by directly oncolysis and inducing immune response through enhancing ROS in human ovarian cancer. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150355
BibTeX
@article{Zhang2024,
author = {Zhang, Guohui and Wang, Qiang and Yuan, Rentao and Zhang, Yanan and Chen, Ke and Yu, Jianlei and Ye, Ting and Jia, Xiaoyuan and Zhou, Yanrong and Li, Gongchu and Chen, Kan},
title = {Oncolytic vaccinia virus harboring aphrocallistes vastus lectin exerts anti-tumor effects by directly oncolysis and inducing immune response through enhancing ROS in human ovarian cancer},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2024.150355}
}
EUVIMED